OTC : EVIO

EVIO, Inc.

$5e-05 USD

$0 (0.0%)

Volume
1M
Average Volume
3.11M
Market Capitalization
$959.68K
P/E Ratio
1.67
Dividend Yield
0.00%
Price Target
Year High
$0.00
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.04
Company Overview

OTC

Lori Jean Glauser

Drug Manufacturers - Specialty & Generic

Healthcare

EVIO

18

US

USD

541 633 4568

30051V106

0000715788

Liquidity Metrics

-0.61

0.04

0.04

0.00

0.00

Sales & Valuation

$1.59M

0.60

-0.01

-1.33

0.00

Profitability

$0

$48000

3.02%

-31.76%

-0.36%

3.65%

P/E Metrics

1.67

0.02

0.02

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

-85.05

3/9

-$7.7M

$953K

$13.45M

-$1.82M

Key Metrics (TTM)

$8.72M

5.48

12.23

0.04

-0.36%

29.93%

59.79%

-74.92%

-1331 days

Company Executives
Name Title
William H. Waldrop Chief Executive Officer & Director
Cheryl Kramp Director of Marketing
Lori Jean Glauser Pres, Chief Operating Officer & Director
Poll Results

No votes yet today — be the first to share your view!

About EVIO, Inc. (OTC:EVIO) Stock

EVIO, Inc., along with its affiliates, provides specialized analytical testing and expert advisory services to the cannabis industry throughout the United States. The company's consulting expertise spans strategic guidance, product formulation assistance, and comprehensive support for licensing and regulatory compliance. Furthermore, EVIO conducts a full range of laboratory analyses, including cannabinoid potency assessment, terpene profiling, pesticide screening, residual solvent detection, visual inspections, and biological contaminant testing. The firm maintains its headquarters in Henderson, Nevada. ...

EVIO Inaugurates New Dorval Office, Strengthening Québec Footprint and Accelerating Growth

2026-06-17 19:26:00

DORVAL, Québec--(BUSINESS WIRE)--EVIO inaugurates new Dorval office, strengthening Québec footprint and accelerating growth.

EVIO Teams with Molicel to Advance Energy Storage Development

2026-05-21 15:53:00

MONTREAL--(BUSINESS WIRE)--EVIO today announced it has entered into a Memorandum of Agreement (MOA) with Molicel to jointly advance the development of next-generation, high energy density lithium-ion cells purpose-built for aerospace applications. The collaboration will focus on advancing battery technologies tailored to enable hybrid-electric flight, supporting the performance, safety, and certification requirements of the EVIO 810 aircraft program and aligning with key upcoming development mi.

Frequently Asked Questions

What is the current EVIO, Inc. (EVIO) stock price?

EVIO, Inc.(OTC:EVIO) stock price is $5e-05 in the last trading session. During the trading session, EVIO stock reached the peak price of $0.0001 while $0.00001 was the lowest point it dropped to. The percentage change in EVIO stock occurred in the recent session was 0.0% while the dollar amount for the price change in EVIO stock was $0.

EVIO's industry and sector of operation?

The OTC listed EVIO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of EVIO?

William H. Waldrop | Chief Executive Officer & Director
Cheryl Kramp | Director of Marketing
Lori Jean Glauser | Pres, Chief Operating Officer & Director
|
|

How many employees does EVIO have?

Number of EVIO employees currently stands at 18. EVIO operates from 2340 West Horizon Ridge Parkway, Henderson, NV 89052, US.

Link for EVIO official website?

Official Website of EVIO is: https://evioinc.com

How do I contact EVIO?

EVIO could be contacted at phone #541 633 4568 and can also be accessed through its website. EVIO operates from 2340 West Horizon Ridge Parkway, Henderson, NV 89052, US.

How many shares of EVIO are traded daily?

The average number of EVIO shares traded daily for last 3 months was 3.11M.

What is the market cap of EVIO currently?

The market value of EVIO currently stands at $959.68K with its latest stock price at $5e-05